Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
Member count: 51-200
Total raised: $49M
Founded date: 2000
Investors 2
Date | Name | Website |
- | Sofinnova ... | sofinnova.... |
- | Boston Mil... | bostonmill... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
24.07.2012 | - | $49M | - | finsmes.co... |
Mentions in press and media 14
Date | Title | Description | Category | Author | Source |
29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |
05.12.2014 | Histogenic... | Histogenics Corporation, a Wal... | USA | - | finsmes.co... |
17.11.2014 | Histogenic... | Histogenics set the per-share ... | - | Brad Perri... | massdevice... |
08.10.2014 | Histogenic... | Histogenics filed for an initi... | - | Alexander ... | massdevice... |
26.07.2012 | Histogenic... | Histogenics Corporation, a Wal... | funding U... | - | finsmes.co... |
24.07.2012 | Fundraisin... | Money raised: $49 million in s... | - | - | medcitynew... |
24.07.2012 | UPDATE: Hi... | Histogenics said it raised ano... | - | MassDevice... | massdevice... |
24.07.2012 | Histogenic... | WALTHAM, MA, Regenerative me... | - | - | vcnewsdail... |
12.10.2011 | Whistleblo... | A Northwestern University card... | - | MassDevice... | massdevice... |
30.05.2011 | Orthopedic... | Histogenics has one product, a... | - | - | medcitynew... |
Show more